Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem
- PMID: 15504889
- PMCID: PMC525443
- DOI: 10.1128/AAC.48.11.4479-4481.2004
Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem
Abstract
We determined the in vitro activities of tigecycline and imipenem against 49 isolates of Acinetobacter baumannii, including those resistant to imipenem. The MIC at which 50% of the isolates were inhibited (MIC(50)) and the MIC(90) for tigecycline and imipenem were 2 and 2 mg/liter and 32 and 128 mg/liter, respectively, with 92 and 20%, respectively, of the strains being susceptible. Tigecycline did not show bactericidal activity in the time-kill studies (n = 9 strains). Imipenem showed bactericidal activity against seven out of nine strains. These in vitro results show that tigecycline has good in vitro bacteriostatic activity against A. baumannii, including strains resistant to imipenem.
Similar articles
-
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.Antimicrob Agents Chemother. 2007 May;51(5):1621-6. doi: 10.1128/AAC.01099-06. Epub 2007 Feb 16. Antimicrob Agents Chemother. 2007. PMID: 17307973 Free PMC article.
-
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.J Antimicrob Chemother. 2007 Aug;60(2):317-22. doi: 10.1093/jac/dkm136. Epub 2007 May 31. J Antimicrob Chemother. 2007. PMID: 17540672
-
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S188-91. doi: 10.1016/S0924-8579(08)70026-8. Int J Antimicrob Agents. 2008. PMID: 19013353
-
In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.J Antimicrob Chemother. 2007 Aug;60(2):421-3. doi: 10.1093/jac/dkm178. Epub 2007 May 31. J Antimicrob Chemother. 2007. PMID: 17540671
-
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.J Antimicrob Chemother. 2007 Apr;59(4):772-4. doi: 10.1093/jac/dkm018. Epub 2007 Mar 12. J Antimicrob Chemother. 2007. PMID: 17353223
Cited by
-
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians.Antibiotics (Basel). 2020 Apr 23;9(4):205. doi: 10.3390/antibiotics9040205. Antibiotics (Basel). 2020. PMID: 32340386 Free PMC article. Review.
-
Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of Escherichia coli and Acinetobacter baumannii.Antibiotics (Basel). 2024 Apr 24;13(5):386. doi: 10.3390/antibiotics13050386. Antibiotics (Basel). 2024. PMID: 38786115 Free PMC article.
-
Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital ICU.Afr J Infect Dis. 2014;8(1):14-8. Afr J Infect Dis. 2014. PMID: 24653812 Free PMC article.
-
Defining, treating and preventing hospital acquired pneumonia: European perspective.Intensive Care Med. 2009 Jan;35(1):9-29. doi: 10.1007/s00134-008-1336-9. Epub 2008 Nov 7. Intensive Care Med. 2009. PMID: 18989656
-
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.J Antimicrob Chemother. 2008 Jul;62(1):45-55. doi: 10.1093/jac/dkn165. Epub 2008 Apr 24. J Antimicrob Chemother. 2008. PMID: 18436554 Free PMC article. Review.
References
-
- Bou, G., G. Cerveró, M. A. Domínguez, C. Quereda, and J. Martínez-Beltrán. 2000. Characterization of nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases. J. Clin. Microbiol. 38:3299-3305. - PMC - PubMed
-
- Cisneros, J. M., M. J. Reyes, J. Pachón, B. Becerril, F. J. Caballero, J. L. García-Garmendia, C. Ortiz, and A. R. Cobacho. 1996. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis. 22:1026-1032. - PubMed
-
- Corbellá, X., M. Pujor, J. Ayats, M. Sendra, C. Ardanuy, M. A. Domínguez, J. Liñares, J. Ariza, and F. Gudiol. 1996. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin. Infect. Dis. 23:329-334. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources